Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO

January 24, 2023

https://www.globenewswire.com/news-release/2023/01/24/2594040/0/en/Decibel-Therapeutics-Announces-Approval-of-Clinical-Trial-Application-by-the-U-K-Medicines-and-Healthcare-Products-Regulatory-Agency-for-Lead-Gene-Therapy-Candidate-DB-OTO.html

The CTA authorization for DB-OTO provides approval for the Company to expand its planned Phase 1/2 clinical trial to the U.K. in patients two years of age and younger

Read more at globenewswire.com

Related news for (DBTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.